Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage.
暂无分享,去创建一个
[1] J. Thorp,et al. Effects of Phenobarbital and Multiple‐Dose Corticosteroids on Developmental Outcome at Age 7 Years , 2003, Obstetrics and gynecology.
[2] D. Henderson-smart,et al. Phenobarbital prior to preterm birth for preventing neonatal periventricular haemorrhage. , 2010, The Cochrane database of systematic reviews.
[3] Douglas G. Altman,et al. Systematic reviews in health care : meta-analysis in context , 2008 .
[4] J. Thorp,et al. 42 Effects of phenobarbital and multiple-dose antenatal/postnatal steroid on developmental outcome at age 7 years , 2001 .
[5] B. Vohr,et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. , 2000, Pediatrics.
[6] R. Haslam,et al. Prenatal thyrotropin-releasing hormone for preterm birth. , 1999, The Cochrane database of systematic reviews.
[7] J. Thorp,et al. Does perinatal phenobarbital exposure affect developmental outcome at age 2? , 1999, American journal of perinatology.
[8] J. Thorp,et al. Antenatal phenobarbital therapy and neonatal income. , 1997, Pediatrics.
[9] J. Thorp,et al. The Effect of Combined Antenatal Vitamin K and Phenobarbital Therapy on Umbilical Blood Coagulation Studies in Infants Less Than 34 Weeks' Gestation , 1995, Obstetrics and gynecology.
[10] J. Thorp,et al. Combined Antenatal Vitamin K and Phenobarbital Therapy for Preventing Intracranial Hemorrhage in Newborns Less Than 34 Weeks' Gestation , 1995, Obstetrics and gynecology.
[11] S. Ramin,et al. A randomized controlled study of the management of asthma complicating pregnancy , 1995 .
[12] I. Tager,et al. Maternal smoking, breast feeding and environmental tobacco smoke (ETS) in the home: Effects on infant urine cotinine levels , 1995 .
[13] J. Thorp,et al. Antepartum Vitamin K and Phenobarbital for Preventing Intraventricular Hemorrhage in the Premature Newborn: A Randomized, Double-Blind, Placebo-Controlled Trial , 1994, Obstetrics and gynecology.
[14] R. Dickson,et al. Antenatal vitamin K therapy of the low-birth-weight infant , 1994 .
[15] I. Miyakawa,et al. Can Prenatal Vitamin K1 (Phylloquinone) Supplementation Replace Prophylaxis at Birth? , 1993, Obstetrics and gynecology.
[16] M. Shearer. Vitamin K metabolism and nutriture. , 1992, Blood reviews.
[17] John C. Sinclair,et al. Effective care of the newborn infant , 1992 .
[18] Y. Brans,et al. Placental Transfer of Vitamin K1 in Preterm Pregnancy , 1990, Obstetrics and gynecology.
[19] N. Simon,et al. Maternal-fetal transport of vitamin K1 and its effects on coagulation in premature infants. , 1989, The Journal of pediatrics.
[20] R. Poland,et al. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants. , 1989, Pediatrics.
[21] R. Knuppel,et al. The use of antenatal vitamin K in the prevention of early neonatal intraventricular hemorrhage. , 1988, American journal of obstetrics and gynecology.
[22] S. Brown,et al. Maternally Administered Antenatal Vitamin K1: Effect on Neonatal Prothrombin Activity, Partial Thromboplastin Time, and Intraventricular Hemorrhage , 1987, Obstetrics and gynecology.